Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$4.6 - $5.44 $285 - $337
-62 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$4.19 - $5.88 $276 - $388
-66 Reduced 51.56%
62 $0
Q4 2020

Feb 11, 2021

BUY
$4.4 - $5.63 $448 - $574
102 Added 392.31%
128 $1,000
Q3 2020

Nov 12, 2020

BUY
$4.75 - $5.99 $123 - $155
26 New
26 $0

Others Institutions Holding ORGS

About Orgenesis Inc.


  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.